Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
15
BIOLQ Quote, Financials, Valuation and Earnings
Last price:
$0.0100
Seasonality move
:
-19.44%
Day range:
$0.0091 - $0.0120
52-week range:
$0.0040 - $0.0960
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
--
Volume:
77.4K
Avg. volume:
57.9K
1-year change:
-89.97%
Market cap:
$333K
Revenue:
$49.2M
EPS (TTM):
-$2.04
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $37.8M | $22.8M | $39.2M | $48.5M | $49.2M | |
| Revenue Growth (YoY) | -18.1% | -39.73% | 72.03% | 23.67% | 1.45% | |
| Cost of Revenues | $23.5M | $16.6M | $22.7M | $32.6M | $32.4M | |
| Gross Profit | $14.3M | $6.2M | $16.5M | $15.9M | $16.7M | |
| Gross Profit Margin | 37.8% | 27.1% | 42.18% | 32.83% | 34.02% | |
| R&D Expenses | $4.8M | $3.7M | $6M | $7.3M | $6M | |
| Selling, General & Admin | $25.1M | $21M | $26.6M | $34M | $28.7M | |
| Other Inc / (Exp) | -$121K | $4.2M | $2.2M | -$438K | -$303K | |
| Operating Expenses | $29.9M | $24.7M | $32.6M | $41.2M | $34.7M | |
| Operating Income | -$15.6M | -$18.5M | -$16.1M | -$25.3M | -$17.9M | |
| Net Interest Expenses | $2.2M | $2.4M | $2.2M | $2.7M | $2.4M | |
| EBT. Incl. Unusual Items | -$17.9M | -$16.7M | -$16.1M | -$28.5M | -$20.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$44K | $128K | $65K | $109K | $31K | |
| Net Income to Company | -$17.9M | -$16.8M | -$16.2M | -$28.6M | -$20.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$17.9M | -$16.8M | -$16.2M | -$28.6M | -$20.6M | |
| Basic EPS (Cont. Ops) | -$1,925.00 | -$1,399.00 | -$283.12 | -$418.13 | -$29.44 | |
| Diluted EPS (Cont. Ops) | -$1,925.00 | -$1,399.00 | -$283.12 | -$418.13 | -$29.44 | |
| Weighted Average Basic Share | $9.3K | $24.5K | $59K | $69K | $1.3M | |
| Weighted Average Diluted Share | $9.3K | $24.5K | $59K | $69K | $1.3M | |
| EBITDA | -$14.8M | -$13.8M | -$13.5M | -$25.3M | -$15.4M | |
| EBIT | -$15.7M | -$14.3M | -$13.9M | -$25.8M | -$18.2M | |
| Revenue (Reported) | $37.8M | $22.8M | $39.2M | $48.5M | $49.2M | |
| Operating Income (Reported) | -$15.6M | -$18.5M | -$16.1M | -$25.3M | -$17.9M | |
| Operating Income (Adjusted) | -$15.7M | -$14.3M | -$13.9M | -$25.8M | -$18.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $6.5M | $9.5M | $12M | $10.9M | $10.9M | |
| Revenue Growth (YoY) | -24.37% | 45.76% | 26.01% | -9.07% | -0.65% | |
| Cost of Revenues | $4.3M | $4.7M | $9.6M | $7.2M | $6.5M | |
| Gross Profit | $2.3M | $4.8M | $2.4M | $3.7M | $4.4M | |
| Gross Profit Margin | 34.78% | 50.8% | 20.36% | 34.3% | 40.39% | |
| R&D Expenses | $963K | $1.5M | $2M | $1.4M | $917K | |
| Selling, General & Admin | $5M | $5.9M | $8.1M | $6.1M | $4.2M | |
| Other Inc / (Exp) | $4.3M | -$65K | -$329K | -$279K | -$116K | |
| Operating Expenses | $5.9M | $7.5M | $10.1M | $7.4M | $5.1M | |
| Operating Income | -$3.7M | -$2.6M | -$7.7M | -$3.7M | -$695K | |
| Net Interest Expenses | $568K | $569K | $424K | $598K | $605K | |
| EBT. Incl. Unusual Items | $27K | -$3.3M | -$8.4M | -$4.6M | -$1.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $15K | $14K | -$17K | $15K | $12K | |
| Net Income to Company | $17K | -$3.3M | -$8.4M | -$4.6M | -$1.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12K | -$3.3M | -$8.4M | -$4.6M | -$1.4M | |
| Basic EPS (Cont. Ops) | -$525.00 | -$54.00 | -$110.36 | -$10.35 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -$525.00 | -$54.00 | -$110.36 | -$10.35 | -$0.04 | |
| Weighted Average Basic Share | $32.5K | $60.8K | $76K | $1.2M | $36.1M | |
| Weighted Average Diluted Share | $32.5K | $60.8K | $76K | $1.2M | $36.1M | |
| EBITDA | $634K | -$2.6M | -$7.9M | -$3.4M | -$166K | |
| EBIT | $595K | -$2.7M | -$8M | -$4M | -$811K | |
| Revenue (Reported) | $6.5M | $9.5M | $12M | $10.9M | $10.9M | |
| Operating Income (Reported) | -$3.7M | -$2.6M | -$7.7M | -$3.7M | -$695K | |
| Operating Income (Adjusted) | $595K | -$2.7M | -$8M | -$4M | -$811K | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $24.4M | $35.3M | $46.8M | $49.7M | $46M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $15.5M | $22.1M | $29.6M | $32.9M | $30.2M | |
| Gross Profit | $9M | $13.2M | $17.2M | $16.8M | $15.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.7M | $5.6M | $6.7M | $6.4M | $4.9M | |
| Selling, General & Admin | $21.3M | $25M | $31.7M | $31.6M | $24.4M | |
| Other Inc / (Exp) | $4.1M | $2.7M | -$957K | -$527K | -$68K | |
| Operating Expenses | $25M | $30.6M | $38.4M | $38.1M | $29.4M | |
| Operating Income | -$16M | -$17.4M | -$21.2M | -$21.3M | -$13.5M | |
| Net Interest Expenses | $2.4M | $2.3M | $1.8M | $3.2M | $2.4M | |
| EBT. Incl. Unusual Items | -$14.3M | -$16.9M | -$24M | -$25M | -$16M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$63K | $73K | $95K | $133K | $36K | |
| Net Income to Company | -$14.3M | -$17M | -$24.1M | -$25.2M | -$16M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$14.3M | -$17M | -$24.1M | -$25.2M | -$16M | |
| Basic EPS (Cont. Ops) | -$1,625.00 | -$379.00 | -$358.34 | -$182.32 | -$2.04 | |
| Diluted EPS (Cont. Ops) | -$1,625.00 | -$379.00 | -$358.34 | -$182.32 | -$2.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$11.2M | -$14.4M | -$21.7M | -$19.6M | -$11M | |
| EBIT | -$12M | -$14.6M | -$22.2M | -$21.8M | -$13.6M | |
| Revenue (Reported) | $24.4M | $35.3M | $46.8M | $49.7M | $46M | |
| Operating Income (Reported) | -$16M | -$17.4M | -$21.2M | -$21.3M | -$13.5M | |
| Operating Income (Adjusted) | -$12M | -$14.6M | -$22.2M | -$21.8M | -$13.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $26.8M | $34.4M | $35.7M | $32.5M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $15.2M | $22.1M | $22.5M | $20.2M | -- | |
| Gross Profit | $11.6M | $12.3M | $13.2M | $12.3M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.5M | $5.2M | $4.4M | $3.3M | -- | |
| Selling, General & Admin | $18.9M | $24.1M | $21.7M | $17.5M | -- | |
| Other Inc / (Exp) | $2.7M | -$552K | -$641K | -$406K | -- | |
| Operating Expenses | $23.4M | $29.2M | $26.1M | $20.8M | -- | |
| Operating Income | -$11.8M | -$16.9M | -$12.9M | -$8.4M | -- | |
| Net Interest Expenses | $1.7M | $1.3M | $1.8M | $1.8M | -- | |
| EBT. Incl. Unusual Items | -$10.9M | -$18.8M | -$15.3M | -$10.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$6K | $23K | $47K | $51K | -- | |
| Net Income to Company | -$10.9M | -$18.8M | -$15.3M | -$10.7M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.9M | -$18.8M | -$15.3M | -$10.7M | -- | |
| Basic EPS (Cont. Ops) | -$204.00 | -$283.34 | -$54.32 | -$0.48 | -- | |
| Diluted EPS (Cont. Ops) | -$204.00 | -$283.34 | -$54.32 | -$0.48 | -- | |
| Weighted Average Basic Share | $174.9K | $198.6K | $2.1M | $87.3M | -- | |
| Weighted Average Diluted Share | $174.9K | $198.6K | $2.1M | $87.3M | -- | |
| EBITDA | -$8.9M | -$17.1M | -$11.4M | -$6.9M | -- | |
| EBIT | -$9.2M | -$17.5M | -$13.5M | -$8.8M | -- | |
| Revenue (Reported) | $26.8M | $34.4M | $35.7M | $32.5M | -- | |
| Operating Income (Reported) | -$11.8M | -$16.9M | -$12.9M | -$8.4M | -- | |
| Operating Income (Adjusted) | -$9.2M | -$17.5M | -$13.5M | -$8.8M | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.8M | $17.6M | $30M | $4.2M | $6.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $8.8M | $3.1M | $4.2M | $5.8M | $5.5M | |
| Inventory | $11M | $11.2M | $12.9M | $15.9M | $11.4M | |
| Prepaid Expenses | $799K | $947K | $1.3M | $1.9M | $826K | |
| Other Current Assets | $364K | $573K | $754K | $1.2M | $555K | |
| Total Current Assets | $27M | $35.1M | $49.4M | $29M | $24.9M | |
| Property Plant And Equipment | $1.5M | $2.8M | $2.8M | $6M | $7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $433K | $231K | $220K | $255K | $268K | |
| Total Assets | $31.8M | $41M | $55.3M | $38.2M | $35.1M | |
| Accounts Payable | $5.3M | $2.7M | $3.3M | $5.8M | $6.1M | |
| Accrued Expenses | $4.2M | $6.2M | $7.3M | $8.1M | $6.2M | |
| Current Portion Of Long-Term Debt | $13.5M | -- | -- | $700K | $2.3M | |
| Current Portion Of Capital Lease Obligations | $323K | $305K | $405K | $638K | $888K | |
| Other Current Liabilities | -- | -- | -- | -- | $1.4M | |
| Total Current Liabilities | $25.8M | $11.2M | $13.8M | $17.8M | $19.7M | |
| Long-Term Debt | -- | $16.2M | $13.6M | $13.1M | $11.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $31.5M | $31M | $30.1M | $33.3M | $35.3M | |
| Common Stock | $31K | $216K | $40K | -- | $3K | |
| Other Common Equity Adj | -$701K | -$385K | -$623K | -$733K | -$553K | |
| Common Equity | $377K | $9.9M | $25.2M | $4.9M | -$247K | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $377K | $10M | $25.2M | $4.9M | -$247K | |
| Total Liabilities and Equity | $31.8M | $41M | $55.3M | $38.2M | $35.1M | |
| Cash and Short Terms | $5.8M | $17.6M | $30M | $4.2M | $6.6M | |
| Total Debt | $13.5M | $16.2M | $13.6M | $13.8M | $14M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18.8M | $33.4M | $10M | $7.8M | $3.4M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $3.4M | $3.6M | $4.8M | $4.4M | $3.5M | |
| Inventory | $12.6M | $14.1M | $16.4M | $13.8M | $9.9M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $903K | $1.4M | $2.6M | $1.8M | $2.6M | |
| Total Current Assets | $36M | $52.7M | $33.9M | $27.8M | $19.4M | |
| Property Plant And Equipment | $2.8M | $2.7M | $5.8M | $7.8M | $4.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.9M | $2.9M | $2.9M | $2.9M | $2.9M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $220K | $222K | $234K | $270K | $260K | |
| Total Assets | $42M | $58.5M | $42.9M | $38.7M | $27.2M | |
| Accounts Payable | $2.6M | $3.6M | $5M | $7.2M | $3M | |
| Accrued Expenses | $3.8M | $5.4M | $6.1M | $4.9M | $5.3M | |
| Current Portion Of Long-Term Debt | $12.9M | $1.4M | -- | $2.8M | $17.6M | |
| Current Portion Of Capital Lease Obligations | $214K | $404K | $615K | $877K | $856K | |
| Other Current Liabilities | -- | -- | -- | $1.5M | $1.4M | |
| Total Current Liabilities | $21.4M | $13.5M | $13.8M | $19.8M | $30.9M | |
| Long-Term Debt | $3.1M | $12.1M | $12.8M | $11.3M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $28.1M | $28.2M | $29M | $38.4M | $32.5M | |
| Common Stock | $234K | $187K | $7K | $2K | $36K | |
| Other Common Equity Adj | -$534K | -$558K | -$1M | -$719K | -$530K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $2.7M | -- | -- | $2.8M | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $13.9M | $30.3M | $13.9M | $332K | -$5.2M | |
| Total Liabilities and Equity | $42M | $58.5M | $42.9M | $38.7M | $27.2M | |
| Cash and Short Terms | $18.8M | $33.4M | $10M | $7.8M | $3.4M | |
| Total Debt | $16.1M | $13.5M | $12.8M | $14.1M | $17.6M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$17.9M | -$16.8M | -$16.2M | -$28.6M | -$20.6M | |
| Depreciation & Amoritzation | $982K | $499K | $400K | $497K | $2.8M | |
| Stock-Based Compensation | $2.7M | $3.4M | $1.7M | $2.3M | $1.2M | |
| Change in Accounts Receivable | $655K | $4.3M | -$978K | -$1.6M | $201K | |
| Change in Inventories | $825K | -$871K | -$1.4M | -$5.8M | $969K | |
| Cash From Operations | -$12.7M | -$12.8M | -$16.7M | -$26.8M | -$14.1M | |
| Capital Expenditures | $207K | $96K | $707K | $3.7M | $1.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$207K | -$96K | -$707K | -$3.7M | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2.5M | $6.1M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$3.7M | -- | -$1M | -$165K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$954K | -$3M | -$1.2M | -- | -- | |
| Cash From Financing | $10.7M | $24.3M | $30M | $4.6M | $17.4M | |
| Beginning Cash (CF) | $8.4M | $6.1M | $17.9M | $30.2M | $4.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.2M | $11.5M | $12.5M | -$25.9M | $2.2M | |
| Ending Cash (CF) | $6.1M | $17.9M | $30.2M | $4.2M | $6.6M | |
| Levered Free Cash Flow | -$13M | -$12.9M | -$17.4M | -$30.5M | -$15.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $17K | -$3.3M | -$8.4M | -$4.6M | -$1.4M | |
| Depreciation & Amoritzation | $39K | $105K | $122K | $560K | $645K | |
| Stock-Based Compensation | $848K | $191K | $591K | $275K | $51K | |
| Change in Accounts Receivable | $384K | $265K | $1.3M | $1.3M | $1.2M | |
| Change in Inventories | -$660K | -$1.3M | -$1.6M | -$557K | $1M | |
| Cash From Operations | -$2.1M | -$3.6M | -$6.5M | -$2.6M | -$4.5M | |
| Capital Expenditures | -$3K | $85K | $2.7M | $182K | $40K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $3K | -$85K | -$2.7M | -$182K | $34K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $2.5M | |
| Long-Term Debt Repaid | -$700K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$5M | -$1K | -- | -- | -- | |
| Cash From Financing | $15.4M | $75K | -$214K | $3.8M | $2.5M | |
| Beginning Cash (CF) | $5.7M | $37.3M | $19.5M | $6.9M | $5.3M | |
| Foreign Exchange Rate Adjustment | $124K | -$88K | -$151K | -$107K | $120K | |
| Additions / Reductions | $13.3M | -$3.6M | -$9.4M | $986K | -$1.9M | |
| Ending Cash (CF) | $19.2M | $33.6M | $10M | $7.8M | $3.4M | |
| Levered Free Cash Flow | -$2.1M | -$3.7M | -$9.2M | -$2.8M | -$4.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$14.3M | -$17M | -$24.1M | -$25.2M | -$16M | |
| Depreciation & Amoritzation | $755K | $253K | $488K | $2.3M | $2.6M | |
| Stock-Based Compensation | $3.1M | $2.5M | $1.9M | $1.7M | $300K | |
| Change in Accounts Receivable | $3.3M | -$148K | -$1.2M | $414K | $546K | |
| Change in Inventories | -$1.5M | -$2.1M | -$3.8M | -$1.2M | $3.1M | |
| Cash From Operations | -$16.1M | -$15M | -$24.3M | -$17.4M | -$13.4M | |
| Capital Expenditures | $147K | $414K | $3.6M | $1.6M | $252K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$147K | -$414K | -$3.6M | -$1.6M | $288K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.9M | -$84K | -- | -- | -- | |
| Cash From Financing | $32.7M | $29.8M | $4.7M | $16.5M | $8.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $16.4M | $14.5M | -$23.1M | -$2.5M | -$4.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$16.3M | -$15.4M | -$27.9M | -$19M | -$13.7M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.9M | -$18.8M | -$15.3M | -$10.7M | -- | |
| Depreciation & Amoritzation | $281K | $369K | $2.1M | $2M | -- | |
| Stock-Based Compensation | $1.5M | $1.7M | $1.1M | $118K | -- | |
| Change in Accounts Receivable | -$417K | -$664K | $1.4M | $1.7M | -- | |
| Change in Inventories | -$2.8M | -$5.2M | -$720K | $1.4M | -- | |
| Cash From Operations | -$13.6M | -$21.2M | -$11.8M | -$11.1M | -- | |
| Capital Expenditures | $396K | $3.3M | $1.1M | $67K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$396K | -$3.3M | -$1.1M | $291K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $2.5M | -- | |
| Long-Term Debt Repaid | -- | -$1M | -- | -$865K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$31K | -- | -- | -- | -- | |
| Cash From Financing | $29.9M | $4.6M | $16.5M | $7.7M | -- | |
| Beginning Cash (CF) | $96.2M | $71.5M | $17.6M | $18.2M | -- | |
| Foreign Exchange Rate Adjustment | -$171K | -$415K | $13K | $22K | -- | |
| Additions / Reductions | $15.9M | -$19.8M | $3.6M | -$3.1M | -- | |
| Ending Cash (CF) | $111.9M | $51.3M | $21.3M | $15.1M | -- | |
| Levered Free Cash Flow | -$14M | -$24.4M | -$12.9M | -$11.2M | -- | |
Get BIOLQ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BIOLQ
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
--
1.80x
Price / LTM sales
0.00x
1.65x
Growth Metrics
BIOLQ
Sector
Revenue growth
-0.65%
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
1.27%
8.01%
Earnings forecast
-$0.01
-$0.20
Profitability
BIOLQ
Sector
Profitability FY 2023
$16.7M
$47.5M
Return on invested capital
-129.74%
-16.26%
Return on assets
-48.28%
-13.27%
Return on equity
-21668.17%
-18.61%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Jul
21
Estimated Next Earnings Date
Feb
6
Balance Sheet
BIOLQ
Sector
Total cash
$3.4M
$35.5M
Short term investments
--
$29.7M
Total assets
$35.1M
$106.9M
Long term debt
$17.6M
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
